Angiotensin converting enzyme inhibitors for cancer treatment?

By Lindberg Henriette   Nielsen Dorte   Jensen Benny   Eriksen Jens   Skovsgaard Torben  

Acta Oncologica, Vol. 43, Iss. 2, 2004-03 ,pp. : 142-152

Informa Healthcare

Access to resources Recommend Favorite

Potential Deployment of Angiotensin I Converting Enzyme Inhibitors and of Angiotensin II Type 1 and Type 2 Receptor Blockers in Cancer Chemotherapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 6, Iss. 5, 2006-09 ,pp. : 451-460

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

By Wilop Stefan   Hobe Sabine   Crysandt Martina   Esser Albert   Osieka Rainhardt   Jost Edgar  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 10, 2009-10 ,pp. : 1429-1435

Springer Publishing Company

Access to resources Recommend Favorite

Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker

By Molteni A.   Moulder J. E.   Cohen E. F.   Ward W. F.   Fish B. L.   Taylor J. M.   Wolfe L. F.   Brizio-Molteni L.   Veno P.  

International Journal of Radiation Biology, Vol. 76, Iss. 4, 2000-04 ,pp. : 523-532

Informa Healthcare

Access to resources Recommend Favorite

Migraine and angiotensin-converting enzyme association in Turkish patients

By Alicakmak Ecir   Cataloluk Osman   Yoldas Tahir   Arslan Ahmet   Herken Hasan   Barlas Omer   Gorucu Senay   Yigiter Remzi  

The Pain Clinic, Vol. 15, Iss. 4, 2003-12 ,pp. : 473-477

Maney Publishing

Access to resources Recommend Favorite